Some artificial intelligence (AI)-focused companies have delivered exceptional returns over the past few years, but some ...

The Company’s presence at ATTD follows compelling clinical performance data from its latest CGM technology developments, which formed the basis for Trinity Biotech’s decision to advance the program ...

Vertex's CF drugs are bringing in billions of dollars in revenue, and in recent years the company has also expanded into ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Tomorrow BioTech and The Super Crowd join forces to give biotech startups labs, crowdfunding, and capital to turn ...

The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest ...

Tomorrow BioTech and Green2Gold unite to support biotech and green innovators with labs, mentorship, and a path to ...

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap ...

Legend Biotech (NASDAQ:LEGN) reported its Q4 earnings results on Tuesday, March 10, 2026 at 07:00 AM. Here's what investors ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

“At the early stage, you’ve got to be hands-on, get involved with everything and everyone, and really understand your own limitations,” he added. For emerging biotechs, this combination of strategic ...

An ASX biotech formerly worth over $500 million has lost most of its value after its drug failed to treat lung cancer ...